Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial.
Victoria Navarro-CompánJames Cheng-Chung WeiFilip Van den BoschMarina MagreyLisy WangDona FleishakerJoseph C CappelleriCunshan WangJoseph WuOluwaseyi DinaLara FallonVibeke StrandPublished in: RMD open (2022)
NCT03502616.
Keyphrases
- double blind
- ankylosing spondylitis
- phase iii
- rheumatoid arthritis
- placebo controlled
- clinical trial
- disease activity
- chronic pain
- phase ii
- pain management
- climate change
- neuropathic pain
- study protocol
- open label
- sleep quality
- systemic lupus erythematosus
- ulcerative colitis
- randomized controlled trial
- postoperative pain
- physical activity
- depressive symptoms